September 2023
1. GILLIS A, Zheng-Pywell R, McLeod C, Wang D, et al
   Somatostatin Receptor Type 2 (SSTR2) and Thyroid Stimulating Hormone Receptor (TSHR) Expression in Oncocytic Thyroid Neoplasms: Implications for Prognosis and Treatment.
   Mod Pathol. 2023 Sep 14:100332. doi: 10.1016/j.modpat.2023.100332.
   

   >> Share

   
   
2. CHOU A, Qiu MR, Crayton H, Wang B, et al
   A detailed histological and molecular assessment of the diffuse sclerosing variant of papillary thyroid carcinoma.
   Mod Pathol. 2023 Sep 14:100329. doi: 10.1016/j.modpat.2023.100329.
   

   >> Share

   
   July 2023
3. NOJIMA S, Kadoi T, Suzuki A, Kato C, et al
   Deep-learning-based differential diagnosis of follicular thyroid tumors using histopathological images.
   Mod Pathol. 2023 Jul 31:100296. doi: 10.1016/j.modpat.2023.100296.
   

   >> Share

   
   June 2023
4. HANG JF, Lee YC
   How Sensitive is Pan-TRK Immunohistochemistry for Detecting NTRK Fusions in Papillary Thyroid Carcinoma?
   Mod Pathol. 2023;36:100222.
   

   >> Share

   
   
5. TORRICELLI F, Santandrea G, Botti C, Ragazzi M, et al
   Medullary thyroid carcinomas classified according to the IMTCGS and a SEER-based metastatic risk score: a correlation with genetic profile and angioinvasion.
   Mod Pathol. 2023 Jun 10:100244. doi: 10.1016/j.modpat.2023.100244.
   

   >> Share

   
   
6. HANG JF, Chen JY, Kuo PC, Lai HF, et al
   A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 WHO Classification: Characterization of 554 Consecutive Tumors with Emphasis on BRAF-Negative Cases.
   Mod Pathol. 2023 Jun 10:100242. doi: 10.1016/j.modpat.2023.100242.
   

   >> Share

   
   
7. LUBIN DJ, Behrman DB, Goyal S, Magliocca K, et al
   Independent Validation of the International Grading System for Medullary Thyroid Carcinoma - A single institutional experience.
   Mod Pathol. 2023 Jun 1:100235. doi: 10.1016/j.modpat.2023.100235.
   

   >> Share

   
   March 2023
8. LEE SE, Lee MS, Bang H, Kim MY, et al
   NTRK Fusion in a Cohort of BRAF p.V600E Wild-type Papillary Thyroid Carcinomas.
   Mod Pathol. 2023 Mar 30:100180. doi: 10.1016/j.modpat.2023.100180.
   

   >> Share

   
   February 2023
9. ASSAAD S, Dov D, Davis R, Kovalsky S, et al
   Thyroid Cytopathology Cancer Diagnosis from Smartphone Images Using Machine Learning.
   Mod Pathol. 2023;36:100129.
   

   >> Share

   
   December 2021
10. SABURI S, Tsujikawa T, Miyagawa-Hayashino A, Mitsuda J, et al
    Spatially resolved immune microenvironmental profiling for follicular thyroid carcinoma with minimal capsular invasion.
    Mod Pathol. 2021 Dec 24. pii: 10.1038/s41379-021-00993.
    

    >> Share

    
    September 2021
11. PARK H, Shin HC, Yang H, Heo J, et al
    Molecular classification of follicular thyroid carcinoma based on TERT promoter mutations.
    Mod Pathol. 2021 Sep 8. pii: 10.1038/s41379-021-00907.
    

    >> Share

    
    July 2021
12. SUSTER D, Michal M, Suster S
    Response and correction to correspondence on "CTNBB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component".
    Mod Pathol. 2021 Jul 27. pii: 10.1038/s41379-021-00876.
    

    >> Share

    
    June 2021
13. AL-OBAIDY KI, Bridge JA, Cheng L, Sumegi J, et al
    EWSR1-PATZ1 fusion renal cell carcinoma: a recurrent gene fusion characterizing thyroid-like follicular renal cell carcinoma.
    Mod Pathol. 2021 Jun 7. pii: 10.1038/s41379-021-00833.
    

    >> Share

    
    April 2021
14. ROUKAIN A, Sykiotis GP
    CTNNB1 mutations in papillary thyroid carcinoma with prominent myofibroblastic stromal component.
    Mod Pathol. 2021 Apr 12. pii: 10.1038/s41379-021-00809.
    

    >> Share

    
    December 2020
15. DOLEZAL JM, Trzcinska A, Liao CY, Kochanny S, et al
    Deep learning prediction of BRAF-RAS gene expression signature identifies noninvasive follicular thyroid neoplasms with papillary-like nuclear features.
    Mod Pathol. 2020 Dec 10. pii: 10.1038/s41379-020-00724.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share